Dyne Therapeutics, Inc share price logo

Dyne Therapeutics, Inc Share Price

NASDAQ: DYN

Mid Cap

$14.15

+0.91

(+6.87%)

Live

as on

Dyne Therapeutics, Inc Stock Performance

as on September 5, 2025 at 9:37 pm IST

  • Day's Low

    Day's High

    $13.2
    $14.22
    downward going graph

    6.71%

    Downside

    0.49%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $6.36
    $37.08
    downward going graph

    55.05%

    Downside

    162.05%

    Upside

    downward going graph

Dyne Therapeutics, Inc share price movements today

Previous Close
$13.24
Open
$13.37
Volume
951.7K
Day's Low - High
$13.2 - $14.22
52 Week Low - High
$6.36 - $37.08

Dyne Therapeutics, Inc Historical Returns

1 Month Return
+ 28.75 %
3 Month Return
-3.65 %
1 Year Return
-59.94 %
3 Year Return
+ 21.66 %
5 Year Return
0 %

Dyne Therapeutics, Inc Stock Fundamentals & Key Indicators

Check Dyne Therapeutics, Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.9B

EPS (TTM)

-3.6515

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0.19

EBITDA

-439.0M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

3599100.00%

Dyne Therapeutics, Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Dyne Therapeutics, Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$1.9BNANA0.00%
BUY$59.4B269.24%-505.15-12.96%
NA$39.4BNANA-3.89%
BUY$101.8B48.94%28.2531.86%
BUY$59.8B-2.26%14.2131.37%

Stock Returns calculator for Dyne Therapeutics, Inc Stock including INR - Dollar returns

The Dyne Therapeutics, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Dyne Therapeutics, Inc investment value today

Current value as on today

₹47,104

Returns

₹52,896

(-52.9%)

Returns from Dyne Therapeutics, Inc Stock

₹57,949 (-57.95%)

Dollar Returns*

₹5,054 (+5.05%)

Analyst Recommendation on Dyne Therapeutics, Inc Stock

Based on 13 analysts

BUY

92.31%

Buy

7.69%

Hold

0.00%

Sell

Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Dyne Therapeutics, Inc. Average target price of $35.35

Dyne Therapeutics, Inc Share Price Target

Get share price movements and forecasts by analysts on Dyne Therapeutics, Inc.

What analysts predicted

59.97%UPSIDE

Target Price

$35.35

Current Price

$14.15

Analyzed by

13 Analysts

Target

$35.35

Dyne Therapeutics, Inc target price $35.35, a slight upside of 59.97% compared to current price of $14.15. According to 13 analysts rating.

Dyne Therapeutics, Inc Stock's Interest Amongst Investors

Search interest for Dyne Therapeutics, Inc Stock has increased by 59% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:59% versus previous 30 day period

Dyne Therapeutics, Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
3
-
-
-
1
-
-
Gross Profit
0
0
0
3
0
0
0
0
0
0
Operating Income
-45
-66
-62
-67
-69
-71
-105
-97
-122
-115
EBITDA
-45
-66
-61
-67
-68
-71
-105
-96
-121
-115
Interest Expense
1
-
-
1
-
-
-
-
-
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-44
-64
-60
-66
-65
-65
-97
-89
-115
-110
Income Tax Expense
-1
-2
0
4
-3
0
-
-
-
-
Net Income
-42
-64
-60
-66
-65
-65
-97
-89
-115
-110
Net Profit Margin
0.00%
0.00%
0.00%
-1759.19%
0.00%
0.00%
0.00%
-5696.06%
0.00%
0.00%

Dyne Therapeutics, Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
842
1,366
506
-
-
-
-
-
-
-
Gross Profit
-1,186
-915
-2,426
0
0
0
-1
-3
-2
-2
Operating Income
64
-640
-412
-4
-13
-58
-150
-170
-242
-343
EBITDA
736
106
949
-4
-14
-57
-148
-169
-233
-315
Interest Expense
546
625
616
0
0
0
0
2
-
-
Depreciation
-
-
-
0
0
0
1
1
1
1
Income Before Tax
-427
-1,289
-538
-4
-14
-59
-149
-168
-235
-317
Income Tax Expense
-474
-45
-610
0
-1
0
0
-2
-235
-
Net Income
50
-1,240
76
-4
-13
-58
-149
-165
-235
-317
Net Profit Margin
5.94%
-90.78%
15.02%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Dyne Therapeutics, Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-64
-60
-66
-65
-65
-97
-89
-115
-110
Operating Cash Flow
-55
-50
-35
-78
-54
-74
-84
-105
-94
Investing Cash Flow
17
12
26
-179
11
-19
-16
1
6
Financing Cash Flow
24
0
0
408
379
18
3
141
100
Change in Cash
-13
-37
-8
150
336
-76
-96
36
12

Dyne Therapeutics, Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-1,240
76
-4
-14
-59
-149
-168
-235
-317
Operating Cash Flow
676
585
-4
-11
-46
-119
-153
-188
-292
Investing Cash Flow
-2,147
-2,759
0
-1
-45
-137
87
83
-204
Financing Cash Flow
2,742
-1,299
12
19
380
157
37
54
809
Change in Cash
1,271
-3,473
12
6
288
-99
-29
-50
313

Global Institutional Holdings in Dyne Therapeutics, Inc

Funds
Holdings
HHG PLC
7.28%
RA Capital Management, LLC
6.83%
BlackRock Inc
5.66%
Vanguard Group Inc
5.21%
FCPM III SERVICES BV
3.84%

Insights on Dyne Therapeutics, Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, DYN stock has moved up by 26.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 80.4% return, outperforming this stock by 141.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 120.8% return, outperforming this stock by 101.3%

About Dyne Therapeutics, Inc

dyne therapeutics, inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the united states. it develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its force platform that delivers disease-modifying therapies. the company was founded in 2017 and is based in waltham, massachusetts.
OrganisationDyne Therapeutics, Inc
Headquarters1560 Trapelo Road, Waltham, MA, United States, 02451
IndustryCommercial Services
CEOMr. John G. Cox M.B.A.
E-voting on sharesClick here to vote

Key Management of Dyne Therapeutics, Inc

Name

Title

Ms. Johanna Friedl-Naderer

Chief Commercial Officer

Dr. Douglas Kerr M.B.A., M.D., Ph.D.

Chief Medical Officer

Mr. Erick J. Lucera C.F.A., CPA

CFO, Principal Financial Officer & Principal Accounting Officer and Treasurer

Dr. Rajesh Manchanda Ph.D.

Chief Technical Officer

Dr. Ranjan Batra Ph.D.

Chief Scientific Officer

Mr. Daniel Wilson

Senior VP & Head of Legal

Mr. John G. Cox M.B.A.

CEO, President & Director

Dr. Oxana Beskrovnaya Ph.D.

Chief Innovation Officer

Mr. James P. Bilotta M.B.A.

Chief Digital & Information Officer

Ms. Lucia Celona

Chief Human Resource Officer

FAQs

What is Dyne Therapeutics, Inc share price today?

Dyne Therapeutics, Inc share price today is $14.15 as on . Dyne Therapeutics, Inc share today touched a day high of $14.22 and a low of $13.2.

What is the 52 week high and 52 week low for Dyne Therapeutics, Inc share?

Dyne Therapeutics, Inc share touched a 52 week high of $37.08 on and a 52 week low of $6.36 on . Dyne Therapeutics, Inc stock price today i.e. is trending at $14.15,which is 61.84% down from its 52 week high and 122.48% up from its 52 week low.

What is Dyne Therapeutics, Inc's market capitalisation today?

Dyne Therapeutics, Inc market capitalisation is $0.00T as on .

How to invest in Dyne Therapeutics, Inc Stock (DYN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Dyne Therapeutics, Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Dyne Therapeutics, Inc Shares that will get you 0.1060 shares as per Dyne Therapeutics, Inc share price of $14.15 per share as on September 5, 2025 at 9:37 pm IST.

What is the minimum amount required to buy Dyne Therapeutics, Inc Stock (DYN) from India?

Indian investors can start investing in Dyne Therapeutics, Inc (DYN) shares with as little as ₹88.233 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.33 in Dyne Therapeutics, Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Dyne Therapeutics, Inc share’s latest price of $14.15 as on September 5, 2025 at 9:37 pm IST, you will get 0.7067 shares of Dyne Therapeutics, Inc. Learn more about fractional shares .